Markets Stocks Economy Crypto Earnings Banking Energy
Home Tech Feature
Tech · Exclusive

SpaceX's first earnings show Starlink strength and AI spend

SpaceX's first earnings show Starlink strength and AI spend
Tech · 2026
Photo · Marcus Devlin for Daily Digest Invest
By Marcus Devlin Equities Correspondent Aug 4, 2026 3 min read

SpaceX reported its first earnings as a public company on [date], revealing that revenue nearly doubled in the April–June quarter to $7.8 billion. The headline number beat expectations, but shares slipped in after-hours trading as investors weighed the company's aggressive spending on artificial intelligence.

Starlink remains the cash engine

The quarter was a classic "cash engine funds the next act" setup. Starlink, the company's satellite internet division, generated more than half of total revenue and grew sales by 66% year over year. That growth helped shrink company-wide operating losses to $143 million from $970 million a year earlier, a dramatic improvement.

Starlink's dominance is not new—it has long been SpaceX's most commercially successful business, with millions of subscribers worldwide. But its role as the primary profit driver is now more critical than ever, as the company funnels capital into its AI ventures.

AI spending jumps

While Starlink powered the top line, SpaceX significantly increased spending to scale its AI business. The company did not break out specific AI revenue or investment figures, but the jump in spending was notable enough to spook some investors, contributing to the after-hours share decline.

SpaceX's AI ambitions are part of a broader trend among tech companies, which are pouring billions into data centers, models, and infrastructure. For SpaceX, the AI push likely leverages its satellite network for data transmission and edge computing, though the company has not detailed its strategy.

What it means for investors

For everyday investors, this earnings report is a reminder that high-growth companies often trade on future promise rather than current profits. SpaceX's revenue growth is impressive, but the market is also pricing in the costs of its AI expansion.

The after-hours dip suggests some investors are worried about the pace of spending. However, the shrinking operating loss shows that Starlink's profitability is helping offset those investments. As one analyst noted, "The market is watching whether Starlink can continue to fund the AI growth without dragging down overall margins."

Investors should also keep an eye on the lock-up period, which restricts insider selling after an IPO. The lock-up expiration could add volatility to the stock. Options traders are already bracing for a 15% swing in the near term.

Broader market context

SpaceX's debut comes at a time when investors are increasingly focused on AI-related earnings. Other companies like Pinterest and Snap have also highlighted AI's role in their growth, though with mixed reactions from the market.

The key question for SpaceX is whether its AI investments will pay off as handsomely as Starlink did. Starlink took years to become profitable, and AI may follow a similar trajectory. For now, the company's ability to nearly double revenue while cutting losses is a positive sign.

Looking ahead

Investors will be watching for more details on SpaceX's AI revenue streams and whether Starlink can maintain its growth pace. The company's next earnings report will be crucial in determining if the AI spending is translating into tangible results.

For now, the takeaway is clear: SpaceX is a growth story with a profitable core, but the market is cautious about the cost of its next big bet. As always, diversification and a long-term perspective are key for everyday investors.

More from this story

Next article · Don't miss

DaVita's per-treatment revenue dips as ACA subsidies end

DaVita's revenue per dialysis treatment slipped in Q2 as more patients left Affordable Care Act plans after pandemic-era subsidies expired. The company still beat profit expectations and reaffirmed its 2026 outlook.

Read the story →
DaVita's per-treatment revenue dips as ACA subsidies end